Aberrant accumulation of Dickkopf 4 promotes tumor progression via forming the immune suppressive microenvironment in gastrointestinal stromal tumor
Abstract Background Drug resistance and tumor recurrence are the major concerns in clinical practices of gastrointestinal stromal tumor (GIST), with the urgent requirement for exploring undiscovered pathways driving malignancy. To deal with these, recent studies have made many efforts to explore pro...
Main Authors: | Ming Wang, Bo Ni, Chun Zhuang, Wen‐Yi Zhao, Lin Tu, Xin‐Li Ma, Lin‐Xi Yang, Zhi‐Gang Zhang, Hui Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2437 |
Similar Items
-
Malignant gastrointestinal stromal tumor
by: P Issar, et al.
Published: (2006-02-01) -
Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives
by: Mulet-Margalef N, et al.
Published: (2016-12-01) -
Multicentric malignant gastrointestinal stromal tumor
by: Shukla Shailaja, et al.
Published: (2009-01-01) -
Gastrointestinal Stromal Tumors: Alexandria University Experience
by: Maher Soliman
Published: (2021-08-01) -
Gastrointestinal stromal tumor with intracranial metastasis: case presentation and systematic review of literature
by: Marc Prablek, et al.
Published: (2019-11-01)